from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2403c/lppR

LFCtreatmentdescriptionclass of inhibitor

-0.412

Amikacinug/mL Amikacintranslation

-1.699

Cap5-10ug/mL Capreomycintranslation

-2.935

Rox10-50 ug/mL Roxithromycintranslation

0.725

SM2-5 ug/mL Streptomycintranslation

-0.615

Tet5-10 ug/mL Tetracyclinetranslation

1.115

Rif0.2-5ug/mL Rifampicintranscription

0.416

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.312

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-2.109

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.226

CPZ10-50 ug/mL Chlorpromazinerespiration

-1.479

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.122

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.060

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.913

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.345

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.276

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.532

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.405

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.904

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.168

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-2.110

KCN5-20 ug/mL Potassium cyaniderespiration

0.019

NaN30.2-2 mM Sodium aziderespiration

-0.338

Nigericin50 uM Nigericinrespiration

0.251

TRC10-150 ug/mL Triclosanrespiration

-0.989

TRZ10-25 ug/mL Thioridazinerespiration

-0.579

Valinomycin0.5-10 uM Valinomycinrespiration

0.579

ZnSO42 mM ZnSO4respiration

0.112

menadione6-10 ug/mL Menadionerespiration

-0.290

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.306

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.362

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.119

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.030

NRP_1Non-replicating persistence stage 1dosRassociated

0.473

Amp0.2mg/mL AmpicillincellWall

-0.168

Cephalexin20-100 ug/mL CephalexincellWall

-0.050

Cerulenin0.32-5 ug/mL CerulenincellWall

0.741

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.300

EMB10-20 ug/mL EthambutolcellWall

0.504

Eta12-40 ug/mL EthionamidecellWall

0.455

INH0.2-0.4 ug/mL IsoniazidcellWall

0.614

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.807

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.938

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.070

BZA0.12 mg/mL BenzamidearomaticAmides

0.300

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.421

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.603

H2O24 mM hydrogen peroxideDNAdamaging

-0.449

Levo10 ug/mL LevofloxacinDNAdamaging

0.915

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-2.042

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.520

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.880

UVUV-irradiationDNAdamaging

-0.497

ARP41-4 ug/mL Antitubercular compound ARP4?

0.019

Antimycin12.5-50 ug/mL Antimycin A?

-0.137

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.088

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.080

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.539

PA8240.2-2 ug/mL PA-824?

-0.822

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.194

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.305

Verapamil50 uM Verapamil?

0.075

mercaptoethanol2 mM 2-Mercaptoethanol?

0.036

methoxatin10-20 ug/mL Methoxatin?